A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Parkinson's Disease
Interventions
DRUG

cannabidiol

"Purified CBD, is a strawberry flavored liquid, in sesame oil, provided as 100 mg/ml, extracted from high CBD plant material.~A component of cannabis that has evidence suggesting it is relatively safe and perhaps neuroprotective, reduces tremor, anxiety and psychosis and is well tolerated in PD. Besides limiting the psychoactive effect of THC, studies support that CBD has anti-inflammatory, anticonvulsant, anti-oxidant, anxiolytic and antipsychotic properties."

Trial Locations (1)

80045

University of Colorado School of Medicine, Aurora

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Colorado Department of Public Health and Environment

OTHER_GOV

collaborator

GW Research Ltd

INDUSTRY

lead

University of Colorado, Denver

OTHER